Chlorpromazine is a phenothiazine (FEEN-oh-THYE-a-zeen) that is used to treat psychotic disorders such as schizophrenia or manic- depression in adults
Chlorpromazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine
Perhaps less familiar to clinicians is the fact that drugs can also trigger other arrhythmias, including bradyarrhythmias, atrial fibrillation/atrial flutter, atrial tachycardia, atrioventricular nodal reentrant tachycardia, monomorphic
Tricyclic antidepressants - first-pass metabolism greater than 50% after oral administration: SNRI antidepressants - venlafaxine: SSRI antidepressants - sertraline: NRI antidepressants - bupropion: Typical antipsychotics - chloropromazine: Atypical
Take it at night to avoid feeling sleepy during the day
It is used to ease anxiety before surgery
4
Unit-Dose cartons of 100, NDC 0832-6019-01
It is a member of the typical antipsychotics or neuroleptic medication category, also known as first-generation antipsychotics
Despite the limited evidence base, this strategy is widely used by clinicians in practice
Chlorpromazine was synthesized on December 11, 1951 by Paul Charpentier, in the laboratories of Rhône-Poulenc, a French pharmaceutical company, and released for clinical investigation in May 1952 as a possible potentiator of general anesthesia ( Charpentier et al 1952 )
Chlorpromazine Hydrochloride Tablets USP, 200 mg are available as white colored, round shaped, biconvex film-coated tablets, imprinted “B5” with black ink on one side and plain on the other side
On the other hand, a new
Chlorpromazine is 10- (3-dimethylaminopropyl)-2-chlorphenothiazine, a dimethylamine derivative of phenothiazine
Drowsiness, dizziness, lightheadedness, dry mouth, blurred vision, tiredness, nausea, constipation, weight gain, or trouble sleeping may occur
Quality of the evidence